Antibacterial effect of ciprofloxacin loaded reduced graphene oxide nanosheets against Pseudomonas aeruginosa strain
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Physicochemical properties of mucus and their impact on transmucosal drug delivery10.1016/j.ijpharm.2017.09.018 ↗
2. Studies on pulmonary secretions. I. The over-all chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy
3. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles10.1016/j.biomaterials.2008.12.076 ↗
4. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus10.1073/pnas.1214066109 ↗
5. Respiratory mucus pH in tracheostomized intensive care unit patients10.1097/00003246-199007000-00003 ↗
6. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy
7. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung10.1038/nature11130 ↗
8. Development of novel alginate lyase cross-linked aggregates for the oral treatment of cystic fibrosis10.1039/c3ra47850e ↗
9. Early pulmonary inflammation in infants with cystic fibrosis
10. Antibacterial properties of doped nanoparticles
11. Antibacterial activity of copper monodispersed nanoparticles into sepiolite10.1007/s10853-006-0432-x ↗
12. Synthesis of copper(ii) coordination polymers and conversion into CuO nanostructures with good photocatalytic, antibacterial and lithium ion battery performances10.1039/c2jm31879b ↗
13. Understanding the pathway of antibacterial activity of copper oxide nanoparticles10.1039/C4RA12163E ↗
14. Enhanced of antibacterial activity of antibiotic-functionalized silver nanocomposites with good biocompatibility10.1007/s10856-019-6236-8 ↗
15. Recent progress in nanoformulations of silver nanoparticles with cellulose, chitosan, and alginic acid biopolymers for antibacterial applications10.1007/s00253-019-10126-4 ↗
16. Green synthesis, characterization and antibacterial activity of silver nanoparticles using Amorphophallus paeoniifolius leaf extract10.1007/s10876-019-01559-y ↗
17. Antibacterial and Cytotoxic Efficacy of Extracellular Silver Nanoparticles Biofabricated from Chromium Reducing Novel OS4 Strain of Stenotrophomonas maltophilia10.1371/journal.pone.0059140 ↗
18. Arakha · 2019 · 287
19. Facile fabrication of highly efficient modified ZnO photocatalyst with enhanced photocatalytic, antibacterial and anticancer activity10.1039/C6RA06774C ↗
20. Enhanced antibacterial activity of Cr doped ZnO nanorods synthesized using microwave processing10.1039/C5RA13375K ↗
21. A study on the antibacterial activity of one-dimensional ZnO nanowire arrays: effects of the orientation and plane surface10.1039/b708662h ↗
22. Fabrication of magnesium oxide nanoparticles by solvent alteration and their bactericidal applications10.1039/C9TB00782B ↗
23. Antibacterial effect of graphene oxide (GO) nano-particles against Pseudomonas putida biofilm of variable age10.1007/s11356-019-05688-9 ↗
24. Green synthesis of silver nanoparticle-decorated porous reduced graphene oxide for antibacterial non-enzymatic glucose sensors10.1007/s11581-016-1954-0 ↗
25. Antibacterial silver nanoparticles supported on graphene oxide with reduced cytotoxicity10.1007/s11837-019-03633-2 ↗
26. A novel controllable molecularly imprinted drug delivery system based on the photothermal effect of graphene oxide quantum dots10.1007/s10853-019-03500-0 ↗
27. In-vitro release study through novel graphene oxide aided alginate based pH-sensitive drug carrier for gastrointestinal tract
28. Bactericidal effect of graphene oxide and reduced graphene oxide: influence of shape of bacteria10.1016/j.colcom.2018.12.001 ↗
29. Functionalized graphene oxide as a Nanocarrier for dual drug delivery applications: the synergistic effect of quercetin and Gefitinib against ovarian Cancer cells10.1016/j.colsurfb.2019.03.037 ↗
30. Construction of high drug loading and enzymatic degradable multilayer films for self-Defense drug release and long-term biofilm inhibition10.1021/acs.biomac.7b01268 ↗
31. Mode of action of the quinolone antimicrobial agents10.1093/clinids/10.Supplement_1.S14 ↗
32. The use of polyethyleneimine-modified reduced graphene oxide as a substrate for silver nanoparticles to produce a material with lower cytotoxicity and long-term antibacterial activity10.1016/j.carbon.2012.02.002 ↗
33. Reduced Graphene Oxide Nanosheets Decorated with Au Nanoparticles as an Effective Bactericide: Investigation of Biocompatibility and Leakage of Sugars and Proteins10.1002/cplu.201402240 ↗
34. DNA and RNA extractions from eukaryotic and prokaryotic cells by graphene nanoplatelets10.1039/C4RA11458B ↗
35. Biocompatibility and hemocompatibility of hydrothermally derived reduced graphene oxide using soluble starch as a reducing agent10.1016/j.colsurfb.2019.110579 ↗
36. Silk sericin induced fabrication of reduced graphene oxide and its in-vitro cytotoxicity, photothermal evaluation10.1016/j.jphotobiol.2018.07.020 ↗
37. Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells10.1016/j.colsurfb.2012.12.036 ↗
38. Review Article10.1002/em.20575 ↗
39. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: a comparative in vitro study10.1016/j.colsurfb.2015.12.030 ↗
40. Interaction analysis of commercial graphene oxide nanoparticles with unicellular systems and biomolecules
41. Improved synthesis of graphene oxide10.1021/nn1006368 ↗
42. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway10.1016/j.pupt.2007.12.001 ↗
43. Experimental reproducibility in flow-chamber biofilms10.1099/00221287-146-10-2409 ↗
44. Thermal reduction of graphene oxide: how temperature influences purity10.1557/jmr.2018.338 ↗
45. Characterization of structural transformation of graphene oxide to reduced graphene oxide during thermal annealing10.1557/jmr.2020.55 ↗
46. High-efficient synthesis of graphene oxide based on improved hummers method10.1038/srep36143 ↗
47. Graphene dendrimer-stabilized silver nanoparticles for detection of methimazole using surface-enhanced Raman scattering with computational assignment10.1038/srep32185 ↗
48. Silver loaded graphene as a substrate for sensing 2-thiouracil using surface-enhanced Raman scattering10.1016/j.snb.2017.07.179 ↗
49. Measuring disorder in graphene with the G and D bands10.1002/pssb.201000247 ↗
50. Mathematical modeling of drug release from swellable polymeric nanoparticles ARTICLE INFO ABSTRACT
51. Modelling of controlled drug release in gastrointestinal tract simulation10.1088/1742-6596/1295/1/012063 ↗
52. Mathematical modeling of drug release profiles for modified hydrophobic HPMC based gels
53. A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles10.1016/j.heliyon.2020.e03451 ↗
54. On the use of the Weibull model to describe thermal inactivation of microbial vegetative cells10.1016/S0168-1605(01)00742-5 ↗
55. Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method10.1093/jac/dkn090 ↗
56. A model-based framework for parallel scale-down fed-batch cultivations in mini-bioreactors for accelerated phenotyping10.1002/bit.27116 ↗
57. Quantitative and Qualitative Assessment Methods for Biofilm Growth: A Mini-review
58. Reduction the Initial-Burst Release of Doxorubicin from Polymeric Depot as a Local Drug Delivery System for Cancer Treatment
59. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells10.1166/jbn.2010.1116 ↗
60. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release10.1023/A:1018908421434 ↗
61. In-vitro release of acyclovir loaded Eudragit RLPO® nanoparticles for sustained drug delivery10.1016/j.ijbiomac.2014.04.019 ↗
62. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa10.2147/IJN.S37397 ↗
63. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress10.1021/nn202451x ↗
64. Macroporous three-dimensional graphene oxide foams for dye adsorption and antibacterial applications10.1039/C5RA19925E ↗